Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension

Abstract : Right ventricle ejection fraction (RVEF) evaluated with magnetic resonance imaging is a strong determinant of patient outcomes in pulmonary arterial hypertension. We evaluated the prognostic value of RVEF assessed with conventional planar equilibrium radionuclide angiography at baseline and change 3-6 months after initiating pulmonary arterial hypertension-specific therapy. In a prospective cohort of newly diagnosed patients with idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension, RVEF was measured at baseline (n=100) and 3-6 months after initiation of therapy (n=78). After a median follow-up of 4.1 years, 41 deaths occurred, including 35 from cardiovascular causes. Patients with a (median) baseline RVEF \\textgreater25% had better survival than those with a RVEF \\textless25% using Kaplan-Meier analysis (p=0.010). RVEF at baseline was an independent predictor of all-cause and cardiovascular mortality in adjusted Cox regression model (p=0.002 and p=0.007, respectively; HR 0.93 for both). Patients with stable or increased RVEF at 3-6 months had a trend for improved all-cause survival (HR 2.43, p=0.086) and had less cardiovascular mortality (HR 3.25, p=0.034) than those in whom RVEF decreased despite therapy. RVEF assessed with conventional planar equilibrium radionuclide angiography at baseline and change in RVEF 3-6 months after therapy initiation independently predict outcomes in patients with pulmonary arterial hypertension.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-lyon1.archives-ouvertes.fr/hal-02192923
Contributor : Marie-Gabrielle Chautard <>
Submitted on : Wednesday, July 24, 2019 - 10:55:53 AM
Last modification on : Thursday, August 8, 2019 - 4:42:06 PM

Links full text

Identifiers

Collections

Citation

P. Y. Courand, G. Pina Jomir, Chahéra Khouatra, C. Scheiber, Ségolène Turquier, et al.. Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension. European Respiratory Journal, European Respiratory Society, 2015, 45 (1), pp.139-49. ⟨10.1183/09031936.00158014⟩. ⟨hal-02192923⟩

Share

Metrics

Record views

6